Abcam plc logo

Abcam plc (ABCZF)

Market Closed
25 Jul, 20:00
OTC PINK OTC PINK
$
22. 25
0
0%
$
5.12B Market Cap
2,225 P/E Ratio
0.16% Div Yield
0 Volume
0 Eps
$ 22.25
Previous Close
Day Range
22.25 22.25
Year Range
22.25 22.25
Want to track ABCZF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ABCZF closed Friday higher at $22.25, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, ABCZF stock gained 0%.
ABCZF pays dividends to its shareholders, with the most recent payment made on Apr 17, 2020. The next estimated payment will be in 17 Apr 2020 on Apr 17, 2020 for a total of $0.041.
The last earnings report, released on Dec 31, 2016, exceeded the consensus estimates by 0.06%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

ABCZF Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Abcam plc Dividends

Abcam plc logo
ABCZF 19 Mar 2020
Paid
Other
$0.04 Per Share
Abcam plc logo
ABCZF 7 Nov 2019
Paid
Other
$0.11 Per Share
Abcam plc logo
ABCZF 14 Mar 2019
Paid
Other
$0.04 Per Share
Abcam plc logo
ABCZF 8 Nov 2018
Other
$0.09 Per Share
Abcam plc logo
ABCZF 15 Mar 2018
Other
$0.03 Per Share

Abcam plc Earnings

31 Dec 2016 Date
-
Cons. EPS
0.06
EPS
30 Sep 2016 Date
-
Cons. EPS
0.06
EPS
30 Jun 2016 Date
-
Cons. EPS
0.07
EPS
31 Mar 2016 Date
-
Cons. EPS
0.07
EPS
31 Dec 2015 Date
-
Cons. EPS
0.06
EPS
Abcam plc logo
ABCZF 19 Mar 2020
Paid
Other
$0.04 Per Share
Abcam plc logo
ABCZF 7 Nov 2019
Paid
Other
$0.11 Per Share
Abcam plc logo
ABCZF 14 Mar 2019
Paid
Other
$0.04 Per Share
Abcam plc logo
ABCZF 8 Nov 2018
Other
$0.09 Per Share
Abcam plc logo
ABCZF 15 Mar 2018
Other
$0.03 Per Share
31 Dec 2016 Date
-
Cons. EPS
0.06
EPS
30 Sep 2016 Date
-
Cons. EPS
0.06
EPS
30 Jun 2016 Date
-
Cons. EPS
0.07
EPS
31 Mar 2016 Date
-
Cons. EPS
0.07
EPS
31 Dec 2015 Date
-
Cons. EPS
0.06
EPS

Abcam plc (ABCZF) FAQ

What is the stock price today?

The current price is $22.25.

On which exchange is it traded?

Abcam plc is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is ABCZF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.16%.

What is its market cap?

As of today, the market cap is 5.12B.

Has Abcam plc ever had a stock split?

No, there has never been a stock split.

Abcam plc Profile

Biotechnology Industry
Healthcare Sector
Mr. Markus Lusser CEO
OTC PINK Exchange
GB00B6774699 ISIN
GB Country
1,760 Employees
7 Nov 2019 Last Dividend
- Last Split
- IPO Date

Overview

Abcam plc is a distinguished life science company established in 1998 with its headquarters in Cambridge, the United Kingdom. The company has carved a niche for itself by focusing on the identification, development, and distribution of essential reagents and tools needed for scientific research, diagnostics, and drug discovery. Abcam plc caters to a diverse clientele, including scientists and researchers in academic institutions and research institutes, as well as those in pharmaceutical, biotechnology, and diagnostics companies. With operations spanning across the Americas, Europe, the Middle East, Africa, China, Japan, and the rest of the Asia Pacific, the company has established a global footprint. Abcam plc stands out for its strategic approach to product distribution by leveraging online sales channels, thereby enhancing accessibility and convenience for its global customer base. As of December 6, 2023, the company became a subsidiary of Danaher Corporation, marking a significant milestone in its evolution and highlighting its value and impact in the life science industry.

Products and Services

Abcam plc offers an extensive range of products and services designed to meet the varied needs of the scientific research community. These include:

  • Primary and Secondary Antibodies: Abcam’s antibodies are meticulously developed to ensure specificity and sensitivity, catering to a broad spectrum of scientific research needs.
  • Conjugated Antibodies and Conjugation Kits: These products facilitate the detection and analysis of proteins, offering researchers versatile tools for their experiments.
  • Singleplex Immunoassays: Designed for precise and specific detection of proteins or biomarkers, these immunoassays support critical research and diagnostic applications.
  • Proteins and Peptides: Including cytokines, this range provides essential molecules for research involving cell signaling, immunology, and various other biological processes.
  • Edited Cell Lines and Lysates: Offering genetically modified cell lines and cell components, these products are invaluable for understanding gene function and protein expression.
  • Cellular Activity Kits: These kits are designed to evaluate cell health, viability, proliferation, and other cellular activities, crucial for drug discovery and toxicology studies.
  • Biochemicals: Abcam supplies a wide variety of biochemicals used in molecular biology, biochemistry, and related areas of research.
  • Cell Signaling Pathway Tools: Catering to the intricate studies of cell signaling pathways, these tools enable a deeper understanding of cellular processes and disease mechanisms.

By providing these comprehensive products and services, Abcam plc significantly contributes to advancing scientific discoveries and innovations in various research fields.

Contact Information

Address: Discovery Drive
Phone: 44 12 2369 6000